ArticleBiophotonics discovery2025
Investigating machine learning algorithms to classify label-free images of pancreatic neuroendocrine neoplasms.
Article in Biophotonics discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Significance: Pancreatic neuroendocrine neoplasms (PNENs) are an uncommon cancer whose incidence rate has increased dramatically in recent years. Surgery is the only potentially curative treatment, which relies on both preoperative tumor localization and postoperative margin definition using histopathological examination for decision making. If pathology could be automated, valuable time and resources could be saved. Aim: In this study, we investigate the ability of machine learning (ML) with handcrafted features, as well as deep learning, to classify label-free microscopy images of PNENs as a first step toward automated pathology of such tumors. Approach: Patient samples of two different preparation types were imaged, and ML and convolutional neural networks (CNNs) were developed to test the ability of such algorithms to classify PNENs. Results: Our classification algorithms were able to distinguish PNENs from normal tissue with high accuracy using multiphoton microscopy (MPM) images, regardless of sample preparation. Using a combined FFPE and fixed frozen dataset, we achieved an AUC value of 0.793 and an accuracy of 80.6% with ML, and an AUC value of 0.977 and an accuracy of 96.43% using CNNs. Conclusions: Label-free MPM combined with deep learning can provide fast, accurate classification of PNENs. With the ability to assess margins rapidly and potentially automatically, both disease recurrence and the need for resections after initial surgery could be reduced.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.